Government Funded Imperial College COVID-19 Vaccine Moves into First Human Trials Clinical researchers will begin human trials of a new coronavirus vaccine developed by researchers at Imperial College London. Published 15 June 2020 From: Department for Business, Energy & Industrial Strategy and The Rt Hon Alok Sharma MP Clinical researchers will begin human trials of a new coronavirus vaccine developed by researchers at Imperial College London. Beginning this week, the study will be the first time the vaccine has been trialled in humans and will test whether it is well-tolerated and produces an effective immune response against COVID-19. This latest milestone follows £41 million in
The post Government Funded Imperial College COVID-19 Vaccine Moves into First Human Trials appeared first on Government Online.